Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Behavioral and Electrophysiological Effects of Ketamine in Treatment-Resistant Depression


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT04239963

Organisation Name: Mclean Hospital

Overal Status: Recruiting

Start Date: August 17, 2020

Last Update: October 22, 2020

Lead Sponsor: Mclean Hospital

Brief Summary: The overarching goal of the present study is to evaluate the effect of a subanesthetic dose of ketamine 24-hour post-injection on resting state functional connectivity, cognitive control, and reward learning.

Conditions:
  • Major Depressive Disorder


Total execution time in seconds: 0.15324401855469